CARE Ratings has reaffirmed the 'CARE AA+; Stable' rating for TVS Holdings' ₹750 crore NCDs and assigned the same rating to a new ₹200 crore NCD facility. The rating is backed by the company's 50.26% stake in TVS Motor Company, which was valued at approximately ₹88,699 crore as of February 2026. This provides a massive debt cover of 94x against the company's gross debt of ₹944 crore. Additionally, the company is expanding its financial services footprint following the 81.04% acquisition of Home Credit India Finance.

MPS Limited has scheduled a conference call for February 18, 2026, to provide details on the acquisition of Unbound Medicine, Inc., USA. The acquisition is being executed through its wholly-owned subsidiary, MPS North America LLC. Chairman and CEO Rahul Arora will lead the discussion to explain the strategic rationale and expected synergies. This move highlights the company's ongoing focus on inorganic growth and expansion within the North American market.

MPS Limited, through its US subsidiary MPS North America LLC, has successfully completed the 100% acquisition of Unbound Medicine, Inc., USA. The transaction was finalized for a total consideration of USD 16.50 million following the satisfaction of customary closing conditions. As a result, Unbound Medicine has become a wholly-owned step-down subsidiary of MPS Limited effective February 9, 2026. This acquisition is part of the company's strategy to expand its footprint in the North American market and enhance its digital health and medical education offerings.

All Time Plastics (ATPL) reported an annual installed capacity of 39,000 tonnes with a 76.6% utilization rate for the nine months ending December 2025. The company is diversifying its portfolio by entering the engineered bamboo segment through a pilot facility in Guwahati and a strategic MoU with NECBDC. ATPL continues to leverage its 'China+1' advantage, exporting to 29 countries while maintaining energy-neutral operations. The presentation underscores a strong focus on high-volume, automated manufacturing and sustainable material usage.

Sterlite Technologies (STL) has announced a preferential issue of 4.53 crore warrants to its promoter entity, Twin Star Overseas Limited, at a price of Rs 110 per warrant. The total fundraise is valued at Rs 498.30 crore, with 25% of the amount (Rs 124.57 crore) to be paid upfront and the remaining 75% upon conversion within 18 months. An Extra-Ordinary General Meeting (EGM) is scheduled for March 4, 2026, to seek shareholder approval for this issuance and necessary amendments to the Articles of Association. This capital infusion by the promoter group is typically viewed as a sign of confidence in the company's future growth and financial stability.

RailTel Corporation of India has secured a significant domestic contract from West Central Railway valued at approximately ₹454.95 crore. The project involves specialized railway works and is scheduled to be completed within 960 days. The final execution deadline is set for September 24, 2028. This substantial order win strengthens RailTel's order book and provides long-term revenue visibility for the company.

Sterlite Technologies (STL) has called an Extraordinary General Meeting on March 4, 2026, to approve a ₹498.30 crore fundraise through a preferential issue of warrants. The company plans to issue 4.53 crore convertible warrants to its promoter, Twin Star Overseas Limited, at a price of ₹110 per warrant. The promoter will pay 25% (₹124.57 crore) upfront, with the remaining 75% payable within 18 months upon conversion into equity. This capital infusion is accompanied by proposed amendments to the Articles of Association to facilitate more flexible future security issuances.

Emami Limited reported a strong Q3 FY26 with consolidated revenue growing 11% YoY to INR 1,152 crores, driven by a robust 9% domestic volume growth. Profit after tax increased by 15% to INR 319 crores, supported by gross margin expansion to 70.6% and EBITDA margin improvement to 33.4%. The company declared a second interim dividend of INR 6 per share, bringing the total 9-month dividend to INR 10. Management highlighted a recovery in rural demand and significant growth in digital channels, with quick commerce sales doubling during the quarter.

LG Balakrishnan & Bros reported a strong Q3 FY26 with consolidated revenue growing 20.6% YoY to Rs 816.56 crore. Consolidated net profit increased by 17.5% YoY to Rs 88.45 crore, even after accounting for a one-time exceptional expense of Rs 11.62 crore related to the New Labour Codes. The core Transmission segment continues to drive growth, contributing over 76% of total revenue. Additionally, the board approved the re-appointment of Dr. Vinay Balaji Naidu as an Independent Director for a second five-year term.

LG Balakrishnan & Bros reported a strong performance for the quarter ended December 31, 2025, with consolidated revenue growing 20.6% YoY to ₹816.56 crore. Net profit for the quarter increased by 17.4% to ₹88.43 crore, despite a one-time exceptional hit of ₹11.62 crore related to new statutory labor codes. The Transmission segment remains the primary growth driver, contributing over 76% of total revenue. The board also recommended the re-appointment of Dr. Vinay Balaji Naidu as an Independent Director for a second five-year term.

LG Balakrishnan & Bros reported a strong performance for the quarter ended December 31, 2025, with consolidated revenue growing 20.6% YoY to ₹816.56 crore. Consolidated net profit increased by 17.5% to ₹88.45 crore, even after accounting for a one-time exceptional expense of ₹11.62 crore related to the implementation of new labor codes. The Transmission segment remains the primary revenue driver, contributing approximately 76% of total income. The company also recommended the re-appointment of Dr. Vinay Balaji Naidu as an Independent Director for a second five-year term.

Max Healthcare Institute Limited (MAXHEALTH) released its latest investor presentation, highlighting its position as India's largest hospital chain by market capitalization at ₹1.02 lakh crore. The company demonstrated robust financial performance with a 4-year EBITDA CAGR of 38% and a revenue CAGR of 24%. Operational efficiency remains high with a 9M FY26 occupancy rate of approximately 76% and a Return on Capital Employed (ROCE) of 26%. The presentation outlines a massive expansion pipeline across Delhi NCR, Mumbai, Lucknow, and Pune to further scale its 5,200+ bed capacity.

India Shelter Finance reported a strong performance for Q3 FY26, with net profit rising 29% YoY to ₹123.9 crore. Total revenue from operations grew 28% YoY to ₹389.5 crore, driven by robust interest income and assignment gains. The company's asset quality remains stable with a Gross NPA of 1.54% and a healthy Liquidity Coverage Ratio of 133.08%. Furthermore, the board has approved a significant capital raise of up to ₹1,000 crore through NCDs to fuel future lending growth.

India Shelter Finance reported a strong Q3FY26 with Gross Managed Assets (GMA) growing 31% YoY to ₹10,365 Cr. Adjusted Profit After Tax (PAT) rose 33% YoY to ₹128 Cr, driven by a 50bps YoY reduction in the cost of funds to 8.3%. While Gross Stage 3 assets saw a slight uptick to 1.5% from 1.2% YoY, the company maintained healthy return ratios with an adjusted RoA of 5.8% and RoE of 17.1%. The company continues its strategic expansion, reaching 301 branches across 15 states with a focus on the self-employed segment.

India Shelter Finance reported a strong Q3FY26 with Gross Managed Assets (GMA) growing 31% YoY to reach Rs 10,365 crore. Adjusted Profit After Tax (PAT) increased by 33% YoY to Rs 128 crore, supported by a 20bps improvement in spreads to 6.6%. While profitability metrics like RoE (17.1%) and RoA (5.8%) showed improvement, asset quality witnessed a slight deterioration with Gross Stage 3 assets rising to 1.5% from 1.2% in the previous quarter. The company continues its expansion strategy, reaching 301 branches across 15 states.

MPS Limited reported a steady 9M FY26 performance with revenue reaching INR 563.2 crores, despite a slight dip in Q3 revenue to INR 182.5 crores. The Education Solutions segment showed robust growth of 38% in the first nine months, while Research Solutions remained the anchor with 61.1% revenue contribution. A major highlight is the USD 16.5 million acquisition of Unbound Medicine, a high-margin subscription business in the medical and nursing sector. Management remains confident in surpassing an EPS of INR 100 for FY26, supported by aggressive cost optimization and new synergies.

India Shelter Finance reported a strong performance for Q3 FY26, with Net Profit increasing 29% YoY to ₹123.9 crore. Total revenue from operations grew by 28% YoY to ₹389.5 crore, supported by robust interest income and fee collections. The company maintains healthy asset quality with a Gross NPA of 1.54% and a Net NPA of 1.16%. Furthermore, the board has approved a significant fundraise of up to ₹1,000 crore through Non-Convertible Debentures (NCDs) to fuel future growth.